Literature DB >> 22661593

FDA approves 18F-florbetapir PET agent.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22661593

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  9 in total

Review 1.  Theranostic nanoparticles for cancer and cardiovascular applications.

Authors:  Dan Wang; Bingbing Lin; Hua Ai
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

2.  Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates.

Authors:  Brittany N Dugger; Christopher M Clark; Geidy Serrano; Monica Mariner; Barry J Bedell; R Edward Coleman; P Murali Doraiswamy; Ming Lu; Adam S Fleisher; Eric M Reiman; Marwan N Sabbagh; Carl H Sadowsky; Julie A Schneider; Simone P Zehntner; Alan P Carpenter; Abhinay D Joshi; Mark A Mintun; Michael J Pontecorvo; Daniel M Skovronsky; Lucia I Sue; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2014-01       Impact factor: 3.685

Review 3.  Development of positron emission tomography β-amyloid plaque imaging agents.

Authors:  Chester A Mathis; N Scott Mason; Brian J Lopresti; William E Klunk
Journal:  Semin Nucl Med       Date:  2012-11       Impact factor: 4.446

4.  Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation.

Authors:  A P Nayate; J G Dubroff; J E Schmitt; I Nasrallah; R Kishore; D Mankoff; D A Pryma
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-12       Impact factor: 3.825

5.  Classification of amyloid status using machine learning with histograms of oriented 3D gradients.

Authors:  Liam Cattell; Günther Platsch; Richie Pfeiffer; Jérôme Declerck; Julia A Schnabel; Chloe Hutton
Journal:  Neuroimage Clin       Date:  2016-05-10       Impact factor: 4.881

6.  Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load.

Authors:  Davneet S Minhas; Julie C Price; Charles M Laymon; Carl R Becker; William E Klunk; Dana L Tudorascu; Eric E Abrahamson; Ronald L Hamilton; Julia K Kofler; Chester A Mathis; Oscar L Lopez; Milos D Ikonomovic
Journal:  Neuroimage Clin       Date:  2018-04-04       Impact factor: 4.881

7.  Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo.

Authors:  L Saint-Aubert; F Nemmi; P Péran; E J Barbeau; P Payoux; F Chollet; J Pariente
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-19       Impact factor: 9.236

8.  NIH workshop on clinical translation of molecular imaging probes and technology--meeting report.

Authors:  Christina H Liu; Antonio Sastre; Richard Conroy; Belinda Seto; Roderic I Pettigrew
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

Review 9.  Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche.

Authors:  Alejandro Luarte; Luis Federico Bátiz; Ursula Wyneken; Carlos Lafourcade
Journal:  Stem Cells Int       Date:  2016-04-19       Impact factor: 5.443
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.